Market Barriers to the Development of Pharmacotherapies for the Treatment of Cocaine Abuse and Addiction: Final Report. Study Methods

09/12/1997

We used several sources to collect information about substance abuse pharmacotherapies (e.g., cocaine) and the market barriers to the development of such drugs. We completed a market analysis for cocaine pharmacotherapy; several hypothetical scenarios of pharmaceutical decisionmaking; four case studies of selected pharmacotherapies; and detailed interviews with five private firms (e.g., pharmaceutical companies, venture capital firms) that have real or potential interest in substance abuse and/or other CNS drug development. The following sections briefly describe our general study methods according to the various study modules; more detailed study methods are described in the appendices.